PHK
TBIO

Point72 Hong Kong’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Point72 Hong Kong’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,416
Closed -$23K – 2518
2021
Q1 		$23K Buy
1,416
+687
+94% +$15.7K ﹤0.01% 1449
2020
Q4 		$13K Sell
729
-734
-50% -$13.1K ﹤0.01% 1497
2020
Q3 		$20K Sell
1,463
-63
-4% -$971 ﹤0.01% 881
2020
Q2 		$27K Buy
+1,526
New +$23K ﹤0.01% 844
2020
Q1 		– Sell
-60
Closed – – 1508
2019
Q4 		$0 Buy
+60
New +$554 ﹤0.01% 1553
2018
Q3 		– Sell
-10,128
Closed -$128K – 1297
2018
Q2 		$128K Buy
+10,128
New +$122K 0.04% 260

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Point72 Hong Kong's TBIO Position: Q2 2021 in Review

Point72 Hong Kong sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 1,416 shares — an estimated $23K sold.

Point72 Hong Kong first reported a position in TBIO in Q2 2018 and held it in 6 quarters. The position peaked at $128K in Q2 2018. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

  • Point72 Hong Kong reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 1,416 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $23K.
  • Point72 Hong Kong first reported a position in Translate Bio, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
  • Point72 Hong Kong's Translate Bio, Inc. Common Stock position peaked at $128K in Q2 2018.
  • 145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on Point72 Hong Kong's 13F filing for Q2 2021, filed 16 Aug 2021.